top of page

Kristen Fortney from BioAge Labs and Martin Borch Jensen from Gordian Biotechnology on longevity

During the Longevity Investors Conference (LIC) 2022 edition, held in the exclusive location of Gstaad in Switzerland, we've had the opportunity to talk to some of the key opinion leaders in the industry. In this rapid fire question mini series, you can get some insights into the current longevity trends, investment advice, as well as hear where the industry is going.

Kristen Fortney and Martin Borch Jensen participated in a few panels during the Longevity Investors Conference, from giving a Longevity industry overview, talking about data and AI application in longevity to explaining how to bridge academia and business. Keep reading for some additional thoughts from Kristen Fortney, CEO and co-founder at BioAge and Martin Borch Jensen, Co-Founder and CSO at Gordian Biotechnology.